The in vitro activity of iron chelator deferiprone against Candida (Candidozyma) auris in combination with antifungal agents

Medical Mycology · Published 2025-12-01 · DOI 10.1093/mmy/myaf116

Authors being retrieved — see the publisher record. https://doi.org/10.1093/mmy/myaf116

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Pathogenicity and virulence of Candida auris · Virulence · 2026 · Cites or is cited by this article
Genomic characterization of sexually transmitted Trichophyton mentagrophytes genotype VII causing genital dermatophytosis in Italy · Medical Mycology · 2026 · Same journal
Detection and molecular characterization of Enterocytozoon bieneusi , Microsporidia, in wild small mammals from Portugal · Medical Mycology · 2026 · Same journal
Co-variation between blood stream infections with Candida species versus Pseudomonas aeruginosa, Staphylococcus aureus , and other isolates among 60 ICU patient cohorts · Medical Mycology · 2026 · Same journal
Human-to-animal transmission cases of the anthropophilic dermatophyte species Trichophyton tonsurans in France, 2021–2025 · Medical Mycology · 2026 · Same journal
Metformin exerts a dual effect on Mucorales virulence by altering oxidative metabolism through the regulation of rhizoferrin levels · Medical Mycology · 2026 · Same journal
First report of terbinafine resistance in human dermatophytosis in Uruguay · Medical Mycology · 2026 · Same journal
Assessment of the PreventID Dermatophyte immunochromatographic test for diagnosing onychomycosis: Integration into routine clinical practice in a tertiary care hospital · Medical Mycology · 2026 · Same journal
Diagnostic performance of IgG against multiplex Aspergillus antigens (mx4) for identifying chronic pulmonary aspergillosis · Medical Mycology · 2026 · Same journal
CAMEO—a cross-sectional survey study on candidemia management in Germany · Medical Mycology · 2026 · Same journal